Valued at USD 416.73 million in 2022, the Nausea Relief Chews Market is projected to reach USD 444.27 million in 2023 and USD 841.40 million by 2032, growing at a CAGR of 7.4% during the forecast period 2023–2032. The report segments the market by indication, distribution channel and region. Competitors include Prestige Consumer Healthcare Inc., Sanofi, Cipla, Pepto Bismol, Emetrol Chewables, Ginger People, Megafood, Mighty Petz, Pink Stork, Sea Calm, Sea-Band, Three Lollies, Upspring and Webber Naturals. Country-level coverage spans the U.S., Canada, the UK, France, Germany, Italy, Spain, the Netherlands, Russia, China, India, Japan, Malaysia, Indonesia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, the UAE, Israel and South Africa. The report uses 2022 as its base year, with historical data from 2019 to 2021 and revenue reported in USD million.

GERD-Related Nausea Emerges as a Growth Indication

The gastroesophageal reflux disease segment is expected to exhibit the highest growth during the projected period, owing to rising global prevalence and a preference for rapid relief of discomfort among individuals with GERD-related nausea. Chews are gradually becoming an effective alternative or complement to prescriptions for managing this nausea. The other indication segment, which covers motion sickness, held the largest share in 2022.

Nausea Relief Chews Market Distribution Channel Shifts

Distribution is segmented into online sales, supermarkets and hypermarkets, hospital pharmacies and others. Online sales are expected to witness the highest growth rate, driven by convenience, wider product selection, complete product information, price comparison and better discounts, and by increasing online shopping trends and a drastic shift in consumer preferences toward online platforms for healthcare products. According to Forbes, around 20.8% of total retail purchases in 2023 were expected to occur online, rising to an estimated 24% by 2026. Global health and beauty e-commerce sales are projected to reach approximately USD 449.6 billion by 2027. Hospital pharmacies led the market with a substantial revenue share in 2022, supported by large patient populations and the physicians, specialists and nurses who prescribe medications, including nausea relief chews.

Regional Insights: North America and Asia Pacific

North America dominated the market in 2022, driven by use in cancer treatment, where rising incidence increases demand for effective products; the American Cancer Society estimates around 1.9 million new cancer cases and 609,360 cancer deaths in the United States. Asia Pacific is anticipated to grow at a healthy CAGR, primarily because of a rising aging population in countries such as India and China, whose members are more likely to experience nausea-related health issues. According to the National Commission of Population, India's elderly population was close to 9% in 2011 and could reach 18% by 2036. Favorable regulations and policies supporting over-the-counter pharmaceuticals also help. In addition, busy urban lifestyles, irregular eating habits and high stress levels contribute to gastrointestinal issues and nausea, boosting demand for quick, convenient solutions.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/nausea-relief-chews-market

Strategic Implications for B2B Stakeholders

The Nausea Relief Chews market is highly fragmented, with large players focusing on partnerships, collaborations, acquisitions, mergers and new product launches to broaden customer reach and enter emerging markets. Stringent regulatory compliance and a limited set of indications remain key restraints. The report also includes PESTLE and value chain analyses and a COVID-19 impact assessment. In the report's Porter's Five Forces analysis, the bargaining power of suppliers and buyers and the threat of substitutes are each rated moderate. For manufacturers and distributors, priorities include strengthening e-commerce capabilities, building relationships with hospital pharmacies, and tailoring products to the needs of older consumers and urban populations. The combination of GERD-related demand, digital retail growth and Asia Pacific demographics points to differentiated opportunities, and these choices will shape competitive positioning in the Nausea Relief Chews Market through 2032.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market